# Qualitative analysis — medgemma-4b-it / test_ood

Case identifiers are configured in `src/eval/qualitative.py` (`CASE_IDS`).

| Case | id | `gemma-3-4b-it` | `gemma-3-4b-it-qlora-finetune` | `medgemma-4b-it` |
|---|---|---|---|---|
| 3 | `test_ood-00207` | `A` ✓ | `B` ✗ | `A` ✓ |

---

## Case 3

- **id**: `test_ood-00207`
- **gold**: `A`
- **predicted**: `A` (parse_success=True)

**Model generation:**

```text
Here's how we can approach this clinical scenario:

*   **Understanding CIN I:** Cervical Intraepithelial Neoplasia grade I indicates mild dysplasia affecting only some cells of the cervix. It represents an early stage of precancerous change.

*   **Management Options Analysis:**

    *   **(A) Close Observation with Pap Smear Screening:** This is generally recommended for low-grade lesions like CIN I because it allows monitoring for progression or regression without immediate intervention. Regular Pap smears help detect changes over time. HPV DNA testing helps determine if there is an associated high risk virus which may be more likely to progress.
    *   **(B) Cryotherapy Ablation:** While cryotherapy can treat CIN I, it's often reserved for higher grades of dysplasia or when close observation isn't feasible due to patient preference or other factors.
    *   **(C) Loop Electrosurgical Excision (LEEP):** LEEP is a surgical procedure used to remove affected tissue. It's typically considered for moderate to severe dysplasias (CIN II, III), persistent infections, or when less invasive methods fail. For CIN I, it might be overtreatment.
    *   **(D) Hysterectomy:** Hysterectomy (removal of the uterus) is a drastic measure usually reserved for cases where cancer has already developed or is highly suspected/confirmed, especially in younger women who desire future childbearing. It would never be indicated for CIN I alone.

*   **Considering the Patient Profile:** The patient is young (28 years old). Given her age and the fact that she is otherwise healthy, conservative management is preferred initially.

*   **Conclusion:** Based on current guidelines, close observation with regular Pap smears and HPV DNA testing is the most appropriate initial management strategy for CIN I in a young, asymptomatic patient.

Answer: A
```
